J.F. Horga

985 total citations
47 papers, 729 citations indexed

About

J.F. Horga is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, J.F. Horga has authored 47 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in J.F. Horga's work include Pain Mechanisms and Treatments (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Epilepsy research and treatment (6 papers). J.F. Horga is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Epilepsy research and treatment (6 papers). J.F. Horga collaborates with scholars based in Spain, United States and Russia. J.F. Horga's co-authors include Pedro Zapater, Antonio G. Garcı́a, Clara C. Faura, Pedro Sánchez‐García, Alejandro Horga, Miguel Pérez‐Mateo, M. Hernández, Ana M. Peiró, José M. Such and Rubén Francés and has published in prestigious journals such as Gastroenterology, The Journal of Physiology and Brain Research.

In The Last Decade

J.F. Horga

46 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.F. Horga Spain 17 181 149 122 108 98 47 729
M S Yates United Kingdom 16 201 1.1× 48 0.3× 140 1.1× 82 0.8× 142 1.4× 56 898
Roberto Medina‐Santillán Mexico 19 113 0.6× 64 0.4× 303 2.5× 59 0.5× 147 1.5× 66 987
Torsten Arndt Germany 18 343 1.9× 54 0.4× 87 0.7× 95 0.9× 276 2.8× 38 1.1k
Xiaoyan Yang China 13 244 1.3× 30 0.2× 72 0.6× 56 0.5× 119 1.2× 38 741
Patricia Compagnon France 17 315 1.7× 116 0.8× 268 2.2× 77 0.7× 110 1.1× 37 1.2k
S. Lindgren Sweden 16 285 1.6× 83 0.6× 197 1.6× 63 0.6× 83 0.8× 38 696
Yuichi Koike Japan 15 141 0.8× 49 0.3× 87 0.7× 63 0.6× 73 0.7× 48 628
Tsutomu Takahashi Japan 17 219 1.2× 42 0.3× 121 1.0× 78 0.7× 110 1.1× 58 775
Gershwin T. Blyden United States 12 125 0.7× 22 0.1× 45 0.4× 148 1.4× 28 0.3× 30 691
J Lecomte France 17 190 1.0× 252 1.7× 126 1.0× 86 0.8× 25 0.3× 66 939

Countries citing papers authored by J.F. Horga

Since Specialization
Citations

This map shows the geographic impact of J.F. Horga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Horga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Horga more than expected).

Fields of papers citing papers by J.F. Horga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Horga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Horga. The network helps show where J.F. Horga may publish in the future.

Co-authorship network of co-authors of J.F. Horga

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Horga. A scholar is included among the top collaborators of J.F. Horga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Horga. J.F. Horga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Martinez, Irma, Rubén Francés, José M. González‐Navajas, et al.. (2018). Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterialDNAin patients with cirrhosis. Liver International. 38(12). 2219–2227. 16 indexed citations
2.
Carrión-Gutiérrez, Miguel A, et al.. (2015). Effects of Curcuma extract and visible light on adults with plaque psoriasis. European Journal of Dermatology. 25(3). 240–246. 31 indexed citations
3.
Peiró, Ana M., et al.. (2011). Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation. Pharmacological Research. 64(1). 80–84. 2 indexed citations
4.
Llanos, Lucía, Rocío Moreu, Ana M. Peiró, et al.. (2010). The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports. Alimentary Pharmacology & Therapeutics. 31(12). 1337–1345. 17 indexed citations
5.
Llanos, Lucía, Rocío Moreu, Ana M. Peiró, et al.. (2009). Causality assessment of liver injury after chronic oral amiodarone intake. Pharmacoepidemiology and Drug Safety. 18(4). 291–300. 9 indexed citations
6.
Díaz‐Cerezo, Silvia, et al.. (2008). [Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam].. PubMed. 45(8). 460–7. 1 indexed citations
7.
Peiró, Ana M., Jesús Novalbos, Pedro Zapater, et al.. (2008). Pharmacogenetic relevance of the CYP2C93 allele in a tenoxicam bioequivalence study performed on Spaniards. Pharmacological Research. 59(1). 62–68. 11 indexed citations
8.
Peiró, Ana M., José Navarro-Martínez, Enrique de‐Madaria, et al.. (2008). Efficacy and Tolerance of Metamizole versus Morphine for Acute Pancreatitis Pain. Pancreatology. 8(1). 25–29. 54 indexed citations
9.
Zapater, Pedro, et al.. (2006). El diagnóstico de los pacientes con sospecha de hepatotoxicidad por fármacos en atención primaria. 4(1). 15–22.
10.
Zapater, Pedro, Rocío Moreu, & J.F. Horga. (2006). The Diagnosis of Drug-Induced Liver Disease. Current Clinical Pharmacology. 1(2). 207–216. 3 indexed citations
11.
Zapater, Pedro, Enrique de‐Madaria, José M. Palazón, et al.. (2006). Functional status of beta-2-adrenoceptor in isolated membranes of mature erythrocytes from patients with cirrhosis and oesophageal varices. Vascular Pharmacology. 44(6). 464–468. 5 indexed citations
12.
Zapater, Pedro, J.F. Horga, José M. Such, et al.. (2004). Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status. Alimentary Pharmacology & Therapeutics. 20(1). 29–36. 37 indexed citations
14.
Zapater, Pedro, José M. Such, Javier Solá-Vera, et al.. (2002). Hepatitis tóxica asociada al uso de tamoxifeno.Presentación de un caso y revisión bibliográfica. Gastroenterología y Hepatología. 25(4). 247–250. 15 indexed citations
15.
Horga, J.F., et al.. (2000). Genetic variability in morphine sensitivity and tolerance between different strains of rats. Brain Research. 866(1-2). 109–115. 18 indexed citations
16.
Horga, J.F., et al.. (2000). A Beta-2-Adrenergic Receptor Activates Adenylate Cyclase in Human Erythrocyte Membranes at Physiological Calcium Plasma Concentrations. Blood Cells Molecules and Diseases. 26(3). 223–228. 25 indexed citations
18.
Faura, Clara C., et al.. (1997). Morphine‐3‐glucuronide prevents tolerance to morphine‐6‐glucuronide in mice. European Journal of Pain. 1(2). 161–164. 7 indexed citations
19.
Faura, Clara C., Michelle Garcia, & J.F. Horga. (1991). Changes in Gentamicin Serum Levels and Pharmacokinetic Parameters in the Newborn in the Course of Treatment with Aminoglycoside. Therapeutic Drug Monitoring. 13(3). 277–280. 9 indexed citations
20.
Faura, Clara C., et al.. (1991). Monitoring Serum Levels of Gentamicin to Develop a New Regimen for Gentamicin Dosage in Newborns. Therapeutic Drug Monitoring. 13(3). 268–276. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026